According to an interview with the people concerned, the Ministry of Health, Labor and Welfare is making final adjustments to decide whether or not to approve the new coronavirus vaccine developed by American pharmaceutical giant Pfizer at a subcommittee on the 12th of this month. ..
If approved, the policy is not to allow the use of vaccine ingredients in people who have had a serious allergic reaction in the past.
Pfizer, the only country in Japan to apply for approval of a new coronavirus vaccine, signed a contract with the Japanese government to supply 72 million people by the end of the year, and last week submitted data from domestic clinical trials to the Ministry of Health, Labor and Welfare.
The Ministry of Health, Labor and Welfare is examining the efficacy and safety together with data from overseas clinical trials, but according to the people concerned, a subcommittee made up of experts will be held on the 12th of this month to decide whether or not to approve it. It means that we have entered into a general adjustment.
If approved, the target of vaccination should be 16 years of age or older for the time being, and the policy is not to allow the use of the vaccine for those who have had a severe allergic reaction such as "anaphylaxis" in the past.
If the subcommittee approves the vaccine, the Ministry of Health, Labor and Welfare is expected to officially approve it within a few days, and the government plans to start vaccination in advance of medical staff as much as possible from the end of this month.